225 related articles for article (PubMed ID: 21882176)
1. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251).
Kadakia KC; Barton DL; Loprinzi CL; Sloan JA; Otley CC; Diekmann BB; Novotny PJ; Alberts SR; Limburg PJ; Pittelkow MR
Cancer; 2012 Apr; 118(8):2128-37. PubMed ID: 21882176
[TBL] [Abstract][Full Text] [Related]
2. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study.
Bavinck JN; Tieben LM; Van der Woude FJ; Tegzess AM; Hermans J; ter Schegget J; Vermeer BJ
J Clin Oncol; 1995 Aug; 13(8):1933-8. PubMed ID: 7636533
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing non-melanoma skin cancers in high-risk groups.
Bath-Hextall F; Leonardi-Bee J; Somchand N; Webster A; Delitt J; Perkins W
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005414. PubMed ID: 17943854
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.
Elmets CA; Viner JL; Pentland AP; Cantrell W; Lin HY; Bailey H; Kang S; Linden KG; Heffernan M; Duvic M; Richmond E; Elewski BE; Umar A; Bell W; Gordon GB
J Natl Cancer Inst; 2010 Dec; 102(24):1835-44. PubMed ID: 21115882
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer.
Bailey HH; Kim K; Verma AK; Sielaff K; Larson PO; Snow S; Lenaghan T; Viner JL; Douglas J; Dreckschmidt NE; Hamielec M; Pomplun M; Sharata HH; Puchalsky D; Berg ER; Havighurst TC; Carbone PP
Cancer Prev Res (Phila); 2010 Jan; 3(1):35-47. PubMed ID: 20051371
[TBL] [Abstract][Full Text] [Related]
6. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials.
Chen K; Craig JC; Shumack S
Br J Dermatol; 2005 Mar; 152(3):518-23. PubMed ID: 15787821
[TBL] [Abstract][Full Text] [Related]
7. Acitretin for chemoprevention of non-melanoma skin cancers in renal transplant recipients.
George R; Weightman W; Russ GR; Bannister KM; Mathew TH
Australas J Dermatol; 2002 Nov; 43(4):269-73. PubMed ID: 12423433
[TBL] [Abstract][Full Text] [Related]
8. Nonmelanoma skin cancer chemoprevention.
Prado R; Francis SO; Mason MN; Wing G; Gamble RG; Dellavalle R
Dermatol Surg; 2011 Nov; 37(11):1566-78. PubMed ID: 21895847
[No Abstract] [Full Text] [Related]
9. A phase III skin cancer chemoprevention study of DFMO: long-term follow-up of skin cancer events and toxicity.
Kreul SM; Havighurst T; Kim K; Mendonça EA; Wood GS; Snow S; Borich A; Verma A; Bailey HH
Cancer Prev Res (Phila); 2012 Dec; 5(12):1368-74. PubMed ID: 23060038
[TBL] [Abstract][Full Text] [Related]
10. The Use of Retinoids for the Prevention and Treatment of Skin Cancers: An Updated Review.
Ramchatesingh B; Martínez Villarreal A; Arcuri D; Lagacé F; Setah SA; Touma F; Al-Badarin F; Litvinov IV
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293471
[TBL] [Abstract][Full Text] [Related]
11. A randomized, 12-year primary-prevention trial of beta carotene supplementation for nonmelanoma skin cancer in the physician's health study.
Frieling UM; Schaumberg DA; Kupper TS; Muntwyler J; Hennekens CH
Arch Dermatol; 2000 Feb; 136(2):179-84. PubMed ID: 10677093
[TBL] [Abstract][Full Text] [Related]
12. Systemic retinoids: chemoprevention of skin cancer in transplant recipients.
Hardin J; Mydlarski PR
Skin Therapy Lett; 2010; 15(7):1-4. PubMed ID: 20700551
[TBL] [Abstract][Full Text] [Related]
13. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial.
Duffield-Lillico AJ; Slate EH; Reid ME; Turnbull BW; Wilkins PA; Combs GF; Park HK; Gross EG; Graham GF; Stratton MS; Marshall JR; Clark LC;
J Natl Cancer Inst; 2003 Oct; 95(19):1477-81. PubMed ID: 14519754
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
15. A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
Chen AC; Martin AJ; Choy B; Fernández-Peñas P; Dalziell RA; McKenzie CA; Scolyer RA; Dhillon HM; Vardy JL; Kricker A; St George G; Chinniah N; Halliday GM; Damian DL
N Engl J Med; 2015 Oct; 373(17):1618-26. PubMed ID: 26488693
[TBL] [Abstract][Full Text] [Related]
16. Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how.
Bettoli V; Zauli S; Virgili A
J Dermatolog Treat; 2013 Jun; 24(3):235-7. PubMed ID: 23148804
[TBL] [Abstract][Full Text] [Related]
17. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.
Clark LC; Combs GF; Turnbull BW; Slate EH; Chalker DK; Chow J; Davis LS; Glover RA; Graham GF; Gross EG; Krongrad A; Lesher JL; Park HK; Sanders BB; Smith CL; Taylor JR
JAMA; 1996 Dec; 276(24):1957-63. PubMed ID: 8971064
[TBL] [Abstract][Full Text] [Related]
18. Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Nemer KM; Council ML
Dermatol Clin; 2019 Jul; 37(3):287-295. PubMed ID: 31084723
[TBL] [Abstract][Full Text] [Related]
19. Systemic retinoid therapy for chemoprevention of nonmelanoma skin cancer in a patient treated with vemurafenib.
Anforth R; Blumetti TC; Mohd Affandi A; Fernandez-Penas P
J Clin Oncol; 2012 Jul; 30(19):e165-7. PubMed ID: 22665544
[No Abstract] [Full Text] [Related]
20. Retinoids in prevention of skin cancer.
Moon TE; Levine N; Cartmel B; Bangert JL
Cancer Lett; 1997 Mar; 114(1-2):203-5. PubMed ID: 9103292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
